WIC
AMRI

Wood Investment Counsel’s Albany Molecular Research Inc AMRI Stock Holding History

Wood Investment Counsel’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$16.2M Buy
+733,328
New +$15M 2.42% 20

Other funds holding AMRI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Wood Investment Counsel's AMRI Position: Q3 2014 in Review

Wood Investment Counsel opened a new position in Albany Molecular Research Inc (AMRI) in Q3 2014: 733,328 shares worth $16.2M. The stake represents 2.42% of the portfolio and ranks #20 among its holdings.

143 funds tracked by Wall St. Rank hold AMRI as of Q3 2014.

  • Wood Investment Counsel held 733,328 shares of Albany Molecular Research Inc worth $16.2M as of Q3 2014.
  • Albany Molecular Research Inc was a new Wood Investment Counsel position in Q3 2014.
  • Albany Molecular Research Inc made up 2.42% of Wood Investment Counsel's portfolio in Q3 2014, its #20 holding.
  • 143 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2014.

Based on Wood Investment Counsel's 13F filing for Q3 2014, filed 27 Oct 2014.